- Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
-
Yang Y, Giau VV, An SSA, Kim S
- KMID: 2545091
- Dement Neurocogn Disord.
- 2023 Apr;22(2):84-84.
- doi: 10.12779/dnd.2023.22.2.84
-
- CITED
-
- Close
- SHARE
-
- Close
- BMD42-2910, a Novel Benzoxazole Derivative, Shows a Potent Anti-prion Activity and Prolongs the Mean Survival in an Animal Model of Prion Disease
-
Hyeon JW, Noh R, Choi J, Lee SM, Lee YS, An SSA, No KT, Lee J
- KMID: 2500521
- Exp Neurobiol.
- 2020 Feb;29(1):93-105.
- doi: 10.5607/en.2020.29.1.93
Prion diseases are a group of neurodegenerative and fatal central nervous system disorders. The pathogenic mechanism involves the conversion of cellular prion protein (PrPC) to an altered scrapie isoform (PrPSc),... -
- CITED
-
- Close
- SHARE
-
- Close
- Executive Summary of the 2019 International Conference of Korean Dementia Association: Exploring the Novel Concept of Alzheimer's Disease and Other Dementia: a Report from the Academic Committee of the Korean Dementia Association
-
Park KH, Lim JS, Seo SW, Jeong Y, Noh Y, Koh eH, Bae Js, Park SA, Yang SJ, Kim HJ, Chin J, Roh Jh, An SSA, Korean Dementia Association
- KMID: 2503503
- Dement Neurocogn Disord.
- 2020 Jun;19(2):39-53.
- doi: 10.12779/dnd.2020.19.2.39
Because of repeated failures of clinical trials, the concept of Alzheimer's disease (AD) has been changing rapidly in recent years. As suggested by the National Institute on Aging and the... -
- CITED
-
- Close
- SHARE
-
- Close
